Pfizer Inc Asset Turnover Ratio (PFE), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pfizer Inc  (NYSE: PFE)
 

Pfizer Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pfizer Inc's asset turnover ratio has remained unchanged compare to previous quarter at 0.3 in the second quarter (Jun 28 2026)

Within sector 116 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2583 to 2588.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PFE Asset Turnover Ratio (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Asset Change -1.14 % 0.58 % -2.58 % -4.9 % -4.67 %
Y / Y Revenue Change 2.6 % 5.37 % -1.16 % -5.92 % 10.31 %
Asset Turnover Ratio (TTM) 0.3 0.3 0.3 0.3 0.3
PFE's Total Ranking # 2588 # 2583 # 2405 # 2483 # 1680
Seq. Asset Change -2.63 % -4.73 % 5.23 % 1.28 % -0.93 %
Seq. Revenue Change 4.03 % -17.69 % 5.42 % 13.66 % 6.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 117
Healthcare Sector # 384
Overall Market # 2588

Asset Turnover Ratio Statistics
High Average Low
7.83 5.29 4.05
(Apr 03 2022)   (Sep. 30, 2009)




PFE Company Profile • Back to PFE Efficiency Comparisons • Compare PFE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 28 2026 Assets at quarter ending Jun 28 2026
Bioventus Inc   0.86 $ 581.106  Millions$ 677.259  Millions
Protalix Biotherapeutics inc   0.85 $ 80.619  Millions$ 94.321  Millions
Amneal Pharmaceuticals Inc   0.85 $ 3,117.474  Millions$ 3,648.680  Millions
Phathom Pharmaceuticals Inc   0.85 $ 239.663  Millions$ 282.908  Millions
Cytosorbents Corporation  0.85 $ 35.663  Millions$ 42.114  Millions
Vivos Therapeutics Inc   0.85 $ 21.135  Millions$ 24.996  Millions
Urogen Pharma Ltd   0.84 $ 188.317  Millions$ 222.945  Millions
Alpha Pro Tech Ltd   0.84 $ 62.204  Millions$ 74.083  Millions
Healthlynked Corp  0.82 $ 1.372  Millions$ 1.671  Millions
Cadre Holdings inc   0.82 $ 686.540  Millions$ 839.780  Millions
Carlisle Companies Incorporated  0.82 $ 5,097.000  Millions$ 6,236.000  Millions
Penumbra Inc  0.81 $ 1,504.874  Millions$ 1,861.012  Millions
Adma Biologics Inc   0.80 $ 510.934  Millions$ 635.581  Millions
West Pharmaceutical Services Inc   0.80 $ 3,326.900  Millions$ 4,140.500  Millions
Irhythm Holdings Inc   0.80 $ 825.702  Millions$ 1,028.762  Millions
Davita Inc   0.80 $ 14,009.646  Millions$ 17,561.212  Millions
Airsculpt Technologies Inc   0.79 $ 150.724  Millions$ 189.626  Millions
Concentra Group Holdings Parent Inc   0.79 $ 2,287.465  Millions$ 2,900.588  Millions
Nexgel Inc   0.79 $ 11.810  Millions$ 15.032  Millions
Labcorp Holdings Inc   0.77 $ 14,348.000  Millions$ 18,568.425  Millions
Iradimed Corporation  0.76 $ 86.339  Millions$ 113.215  Millions
Lifeward ltd   0.76 $ 21.822  Millions$ 28.622  Millions
Msa Safety Inc  0.76 $ 1,946.916  Millions$ 2,568.362  Millions
Harmony Biosciences Holdings inc   0.75 $ 960.191  Millions$ 1,281.189  Millions
Sight Sciences Inc   0.75 $ 83.351  Millions$ 111.533  Millions
Novocure Limited  0.75 $ 699.193  Millions$ 937.159  Millions
Verrica Pharmaceuticals Inc   0.74 $ 30.321  Millions$ 40.707  Millions
Staar Surgical Co  0.74 $ 339.590  Millions$ 458.591  Millions
Adapthealth Corp   0.74 $ 3,226.709  Millions$ 4,366.244  Millions
Dexcom Inc   0.74 $ 4,968.800  Millions$ 6,732.125  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.